|本期目录/Table of Contents|

[1]周 玮,杜云翔,王建国,等.高糖波动对MG63细胞株护骨素与TRAIL表达的影响[J].医学研究与战创伤救治(原医学研究生学报),2012,14(02):141-144.
　ZHOU Wei,DU Yun-xiang,WANG Jian-guo,et al.Effects of high glucose fluctuation on expressions of TRAIL and OPG in MG63 cells[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2012,14(02):141-144.
点击复制

高糖波动对MG63细胞株护骨素与TRAIL表达的影响()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第14卷
期数:
2012年02期
页码:
141-144
栏目:
出版日期:
2012-03-20

文章信息/Info

Title:
Effects of high glucose fluctuation on expressions of TRAIL and OPG in MG63 cells
文章编号:
1672-271X(2012)02-0141-04
作者:
周 玮; 杜云翔; 王建国; 王加林
223001 江苏淮安，解放军82医院内分泌科
Author(s):
ZHOU Wei; DU Yun-xiang;  WANG Jian-guo; WANG Jia-lin.
Department of Endocrinology，82 Hospital of PLA，Huai’an，Jiangsu 223001， China
关键词:
高糖波动; MG63细胞; 肿瘤坏死因子相关凋亡诱导配体
Keywords:
high glucose fluctuation;  MG63 cell;  tumor necrosis factor-related apoptosis-inducing ligand
分类号:
R574
DOI:
-
文献标志码:
A
摘要:
目的 研究波动性葡萄糖和恒定高葡萄糖对MG63细胞株肿瘤坏死因子相关凋亡诱导配体(tumor necrosis factor-related apoptosis-inducing ligand，TRAIL)、护骨素(osteoprotegerin，OPG)和其配体(osteoprotegerin ligand，OPGL)表达的影响，探讨高糖波动在糖尿病性骨质疏松症发病中的作用。方法 体外培养的人成骨肉瘤MG63细胞株，随机分为正常对照组(NG组，葡萄糖浓度为5.5 mmol/L)；恒定高葡萄糖组(HG组，葡萄糖浓度为33.3 mmol/L)；波动性葡萄糖组(FG组，葡萄糖浓度为5.5 mmol/L与葡萄糖浓度为33.3 mmol/L两种培养液，每8 h更换一次)，共作用24 h。四甲基偶氮唑蓝(MTT)比色分析法测定细胞增殖，流式细胞仪检测细胞周期及凋亡率。RT-PCR法检测TRAIL、OPG、OPGL mRNA的表达。结果 ①高糖及高糖波动可抑制MG63细胞的增殖，与HG组相比，FG组的抑制效应更加明显。②高糖及高糖波动可阻滞MG63细胞周期，使G1期细胞比例增加，S期比例减少，诱导细胞凋亡。FG组作用更加明显(P＜0.05)。③高糖作用下MG63细胞中TRAIL和OPGL基因表达增加，而OPG基因表达下降，FG组较HG组上述作用更加明显(P＜0.05)。结论 高糖波动可能导致成骨细胞中TRAIL和OPGL表达增多，OPG的表达减少，抑制成骨细胞增殖，阻滞其细胞周期，诱导细胞凋亡，可能是糖尿病性骨质疏松症的一个重要的发病机制。
Abstract:
Objective To observe the regulative effects of glucose at different concentrations on the expressions of tumor necrosis factor-related apoptosis,which inducing ligand(TRAIL),osteoprotegerin(OPG),and the ligand of osteoprotegerin(OPGL) in osteosarcoma MG63 cells in order to study the role of high glucose fluctuation in pathogenesis of diabetic osteoporosis.Methods MG63 cells were randomly divided into the following medium containing 5.5 mmol/L glucose(Normal glucose group,NG group),33.3 mmol/L glucose(High glucose group,HG group) and 5.5/33.3 mmol/L glucose(high glucose fluctuation of different amplitude 5.5/33.3 mmol/L group,FG group) and cultured in vitro for 24 h.The proliferation of MG63 cells was examined by MTT colorimetric analysis.The cell cycle and apoptotic rate of cells were determined by flow cytometry.The expressions of TRAIL,OPG and OPGL mRNA were detected by RT-PCR.Results Both high glucose and high glucose fluctuation inhibited the proliferation of MG63 cells，and the effect of high glucose fluctuation was significantly higher than that in high glucose(P＜0.05).Both high glucose and high glucose fluctuation blocked cell cycle,increased the percentage of G1 phase,decreased the percentage of S phase and induced apoptosis.The effect of high glucose fluctuation was obviously stronger than that in high glucose(P＜0.05).The mRNA expressions of TRAIL and OPGL in MG63 cells significantly increased and the expression of OPG mRNA decreased under high glucose environment(P＜0.05).The mentioned effects were obviously power in FG group than that in HG group.Conclusion High glucose fluctuation could not only inhibit the proliferation,block cell cycle,induce apoptosis,and also lead to the increasing expressions of TRAIL and OPGL,but the decreasing expression of OPG in osteoblasts,which may be one of the key pathogenetic factors of diabetic osteoporosis.

参考文献/References:

[1]廖二元，超楚生，伍汉文.内分泌学[Ｍ].北京:人民卫生出版社，2001:1818-1819. 表3 不同浓度葡萄糖对MG63细胞OPG、OPGL及TRAIL mRNA表达的影响(x±s) 组别nOPGOPGLTRAILOPG/OPGLNG组50.961±0.0270.109±0.0340.739±0.0238.785±0.561HG组50.929±0.019a0.181±0.022a0.884±0.035a5.107±0.441aFG组5 0.904±0.075ab 0.222±0.020ab 0.905±0.041ab 4.085±0.417ab 注:与NG组比较，aP＜0.05；与HG组比较，bP＜0.05
[2]Wongdee K， Charoenphandhu N.Osteoporosis in diabetes mellitus:possible cellular and molecular mechanisms [J].World J Diabetes， 2011，2(3): 41-48.
[3]Sanchez-Nio MD， Benito-Martin A， Goncalves S,et al.TNF superfamily:s growing saga of kidney injury modulators[J].Mediators Inflamm， 2010,2010: 182958.
[4]van den Oever IA，Raterman HG,Nurmohamed MT,et al.Endothelial dysfunction，inflammation，and apoptosis in diabetes mellitus[J].Mediators Inflamm，2010,2010: 792393.
[5]Wright HL，McCarthy HS，Middleton J， et al.Rank,ralkl and osteoprotegerin in bone biology and disease[J].Curr Rev Musculoskelet Med， 2009，2(1): 56-64.
[6]周 玮，姬秋和，张南雁，等.不同浓度葡萄糖对MG63细胞株护骨素、护骨素配体及其相关因子表达的影响[J].医学研究生学报，2007，20(2):146-149.
[7]Matsuda T，Almasan A， Tomita M，et al.Resistance to Apo2 ligand(apo2L)/tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-mediated apoptosis and constitutive expression of apo2L/trail in human T-cell leukemia virus type 1-infected T-cell lines [J].J Virol， 2005，79(3): 1367-1378.
[8]Narducci P，Bortul R，Bareggi R， et al.Clathrin-dependent endocytosis of membrane-bound RANKL in differentiated osteoclasts [J].Eur J Histochem,2010，54(1): e6.
[9]Bell NH.Rank ligand and the regulation of skeletal remodeling[J].J Clin Invest，2003，111(8):1120-1122.
[10]Hofbauer LC， Khosla S， Dunstan CR， et al.The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption[J].J Bone Miner Res， 2000，15(1):2-12.
[11]Bai XC，Lu D，Liu AL，et al.Reactive oxygen species stimulates receptor activator of NF-kB ligand expression in osteoblast[J].J Biol Chem，2005，280(17):17497-17506.
[12]Boyce BF， Xing L.Biology of RANK，RANKL，and osteoprotegerin[J].Arthritis Res Ther,2007,9(Suppl 1): S1.
[13]罗助荣.骨保护素系统与动脉粥样硬化的研究进展[J].东南国防医药，2010，12(6):523-525.

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2012-03-20